Significance of the anti-Ro(SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease

Journal of the American Academy of Dermatology

Volumn 35, Issue 2 PART I, 1996, Pages 147-169

  Provost, Thomas T ^a,c   Watson, Rosemarie ^b   Simmons O'Brien, Eva ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST JAMES S HOSPITAL   (Ireland)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C4; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MATERNAL ANTIBODY; PRECIPITIN; RO ANTIBODY; UNCLASSIFIED DRUG;

ARTHRALGIA; ARTHRITIS; COMPLEMENT DEFICIENCY; CONNECTIVE TISSUE DISEASE; DERMATITIS; HUMAN; INTERSTITIAL LUNG DISEASE; KIDNEY DISEASE; MYOSITIS; PERIPHERAL NEUROPATHY; PHOTOSENSITIVITY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; SJOEGREN SYNDROME; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

ANTIBODIES, ANTINUCLEAR; ANTIBODY SPECIFICITY; CONNECTIVE TISSUE DISEASES; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, DISCOID; LUPUS ERYTHEMATOSUS, SYSTEMIC; PHOTOSENSITIVITY DISORDERS; SKIN DISEASES;

EID: 0029762169     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(96)90315-1     Document Type: Article

References (24)

1. Clark G, Reichlin M, Tomasi TB Jr. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol 1969;102:117-22.
2. Mattioli M, Reichlin M. Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Arth Rheum 1974;17:421-9.
3. Alspaugh MA, Tan EM. Antibodies to cellular antigens in Sjögren's syndrome. J Clin Invest 1975;55:1067-73.
4. Alspaugh MA, Maddison P. Relation of the identity of certain antigen/antibody systems is systemic lupus erythematosus and Sjögren's syndrome: an interlaboratory collaboration. Arthritis Rheum 1979;22:796-8.
5. Anderson JR, Gray KG, Beck JS. Precipitating autoantibodies in Sjögren's disease. Lancet 1961;2:456-60.
6. Anderson JR, Gray KG, Beck JS. Precipitating autoantibodies in the connective tissue diseases. Ann Rheum Dis 1962;21:360-70.
7. Bloch KH, Buchanan WW, Wohl MJ, et al. Sjögren's syndrome: a clinical, pathological, and serologic study of 62 patients. Medicine 1965;44:187-200.
8. Rowell MR, Swanson-Beck J, Anderson JR. Lupus erythematosus and erythema multiforme-like lesions. Arch Dermatol 1963;88:176-80.
9. Provost TT, Ahmed AR, Maddison PJ, et al. Antibodies to cytoplasmic antigens in lupus erythematosus: serologic marker for systemic disease. Arthritis Rheum 1977;20:1457-61.
10. Provost TT, Andres G, Maddison PJ, et al. Lupus band in untreated SLE patients: correlation of immunoglobulin deposition in the skin of the extensor forearm with clinical renal disease and serologic abnormalities. J Invest Dermatol 1980;74:407-12.
11. Sontheimer RD, Thomas JR, Gilliam JD. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 1979;115:1409-15.
12. Maddison PJ, Provost TT, Reichlin M. Serologic findings in patients with "ANA negative" SLE. Medicine 1981;60:87-94.
13. Doré N, Synkowski DR, Provost TT. Antinuclear antibody determinations in Ro(SS-A)-positive, antinuclear antibody-negative lupus and Sjögren's syndrome patients. J Am Acad Dermatol 1983;8:611-5.
14. Sontheimer RD, Maddison PJ, Reichlin M, et al. Serologic and HLA associations of subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med 1982;97:664-71.
15. Simmons-O'Brien E, Chen S, Watson R, et al. 100 antiRo(SS-A) antibody positive patients: a ten year follow-up. Medicine 1995;74:109-30.
16. Reichlin M, Rader M, Harley JB, et al. Autoimmune responses to Ro(SS-A) particle are directed to the human antigen. Clin Exp Immunol 1989;76:373-7.
17. Provost TT, Levin LS, Watson RM, et al. Detection of anti-Ro(SS-A) antibodies by gel double diffusion and a sandwich ELISA in systemic and subacute cutaneous lupus erythematosus and Sjögren's syndrome. J Autoimmun 1991;4:87-96.
18. McCauliffe DP, Sontheimer RD. Molecular characterization of the Ro(SS-A) autoantigens. J Invest Dermatol 1993;100(suppl):73S-79S.
19. Deutscher SL, Harley JB, Keene JD. Molecular analysis of the 60 kDa human Ro ribonuclear protein. Proc Natl Acad Sci U S A 1988;85:9479-83.
20. Ben-Chetrit E, Gandy BJ, Tan EM, et al. Isolation and characterization of a cDNA clone encoding the 60 kD component of the human SS-A/Ro ribonuclear protein autoantigen. J Clin Invest 1989;83:1284-92.
21. Boire G, Craft J. Human Ro ribonuclear protein particles: characterization of native structure and stable association with the La polypeptide. J Clin Invest 1990;85:1182-90.
22. Gottlieb E, Steitz JA. The RNA binding protein law influences both the accuracy and the efficiency of RNA polymerase ni transcription in vitro. Eur Mol Biol Organ J 1989;8:841-50.
23. Gottlieb E, Steitz JA. Function of the mammalian La protein: evidence for its action in transcription termination by RNA polymerase III. Eur Mol Biol Organ J 1989;8:851-62.
24. McCauliffe DP, Lux FA, Lieu TS, et al. Molecular cloning: expression and chromosome 19 localization of a human Ro(SS-A) autoantigen. J Clin Invest 1990;85:1379-91.